Cognitive dysfunction associated with Non-Central Nervous System (Non-CNS) cancer has
emerged as a new area of clinical interest and research. The cause of Non-CNS cancer …

Objective Cognitive impairment in primary and metastatic brain cancers has been well-
documented. However, there is a lack of research comparing the cognitive profiles of people …

Purpose Individuals with non-central nervous system (CNS) cancers can experience cancer-
related cognitive dysfunction (CRCD), negatively impacting daily functioning and quality of …

Abstract Purpose of Review This review is intended to provide a summary of the current
literature on cancer-related cognitive impairment (CRCI) to support practitioners and …

Objectives Cancer‐related cognitive impairments (CRCI) are common after treatment and
can have important impacts on the lives of adolescent and young adult (AYA) cancer …

Cancer-related cognitive dysfunction (CRCD) is a prevalent problem among cancer
survivors and can have a significant negative influence on survivor quality of life and …

Cancer-related cognitive impairment (CRCI) has increasingly been identified over the last
two decades in non-CNS system cancer patients. Across Europe, researchers have …

Cancer-related cognitive impairment (CRCI) is commonly experienced by individuals with
non-central nervous system cancers throughout the disease and treatment trajectory. CRCI …

Cancer and its treatments can have a broad influence on brain structure and function.
Therapeutic toxicities, systemic comorbidities, structural brain lesions, and psychosocial …

Answer questions and earn CME/CNE Over the past few decades, a body of research has
emerged confirming what many adult patients with noncentral nervous system cancer have …